1999 perspective in drug industry: Revised Medical Affairs Law.

Published: 1999-01-14 14:06:00

Updated: 1999-01-14 14:06:00

The government prepared the revised draft of the Medical Affairs Law in line with the deregulation and reform plans for the purpose of enhancing efficiency of the medical service for people, and presented it to the Health and Welfare Commission of the National Assembly. However, it was delayed du...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK